BioSpace News Archive

Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19). Date January 22, 2021 Time 12:30 PM (EST) Location The news conference will be held virtually. Journalists who wish to ask questions can do so by teleconference. Toll-free ( Canada /US) di

Vancouver, British Columbia--(Newsfile Corp. - January 22, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTC Pink: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce its inclusion in the Horizon North American Psychedelic ETF, the first ever psychedelic ETF of its kind.

FDA recognizes importance of increased availability of devices such as market leading TEG® hemostasis analyzers

Ten of the world’s leading biopharmaceutical companies today announced the formation of a new non-profit corporation, Accumulus Synergy, Inc., which is intended to support interactions between industry and health authorities worldwide to enable real-time collaboration and data exchange, as well as data submission.

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the release of its inaugural ESG Report, which details the company’s commitments and efforts to build strong corporate governance, and operate sustainably and responsibly, including its response to the COVID-19 pandemic and prevailing social issues in 2020.

OrthoPediatrics Corp., a company exclusively focused on advancing the field of pediatric orthopedics, continues to expand their product offering in Australia and New Zealand.

The rising prevalence of infectious and chronic diseases amongst a large pool of female population is expected to offer a positive impetus to the demand for effective treatment, paving way for the development of femtech market over the span of 2019 to 2025.

he global negative pressure wound therapy (NPWT) market is slated to record substantial gains in the coming years, driven by an increasing number of accident-related trauma and injuries.

Strong focus on offering safe and microbe-free biologics & pharmaceutical products is likely to proliferate global biological safety testing market share over 2019-2025.

Dr. John C. Landon, past president, CEO and former chairman of the board of BIOQUAL, passed away Sunday, January 10, 2021, at the age of 84. John was born and raised in Hornell, New York, and went on to earn a B.A. degree in biology from Alfred College (class of 1959) and M.S. and Ph.D. degrees in biology from The George Washington University in 1962 and 1967,